I would guess it would be with Pfizer Inc. Hold on, M&A area is finally going bullish. Today, should be a positive and great day for ACTC due to the article from Bloomberg.
Sentiment: Strong Buy
Wrong-the article you cite was out of context. It only was related to Japan article of Abe funding stem cells and that both Pfizer and ACTC were working on treatments separately ------NOT TOGETHER!